Glaxo Pays $90 Million to Settle States’ Avandia Claims
Glaxo Pays $90 Million to Settle States’ Avandia Claims Bloomberg
View ArticleGlaxo Plaintiff Lawyers Settle Dispute Over $143 Million
Glaxo Plaintiff Lawyers Settle Dispute Over $143 Million Bloomberg
View ArticleGlaxoSmithKline says Guardian wrong to suggest Avandia safety data concealed
GlaxoSmithKline says Guardian wrong to suggest Avandia safety data concealed The Fly on the Wall
View ArticleGlaxo Sued By Maryland AG Over Avandia Risks
Glaxo Sued By Maryland AG Over Avandia Risks Pharmalot
View ArticleFDA reviewing heart risks of Glaxo diabetes pill
FDA reviewing heart risks of Glaxo diabetes pill Yahoo/AP
View ArticleFDA To Review Controversial Avandia Clinical Trial In June
FDA To Review Controversial Avandia Clinical Trial In June Pharmalot
View ArticleSteve Nissen: The FDA Meeting On Avandia Will Be A 'Whitewash'
Steve Nissen: The FDA Meeting On Avandia Will Be A 'Whitewash' Pharmalot
View ArticleGlaxo Alleges Errors In Nissen's Critique Of FDA's Handling Of Avandia...
Glaxo Alleges Errors In Nissen's Critique Of FDA's Handling Of Avandia Comment Now Follow Comments Forbes
View ArticleSpinning RECORD: Battle Over Avandia Heats Up Two Weeks Before Crucial FDA...
Spinning RECORD: Battle Over Avandia Heats Up Two Weeks Before Crucial FDA Meeting Forbes
View ArticleControversial Analysis Of Disputed Trial Finds Avandia Is Safe, After All
Controversial Analysis Of Disputed Trial Finds Avandia Is Safe, After All Pharmalot
View ArticleFDA panel to consider lifting restrictions on Avandia based on new heart risk...
FDA panel to consider lifting restrictions on Avandia based on new heart risk analysis Yahoo/AP
View ArticleBattleground FDA: How Wednesday's Avandia Panel Could Help Shape The Future...
Battleground FDA: How Wednesday's Avandia Panel Could Help Shape The Future Of Diabetes Forbes
View ArticleFDA Avandia Panel: A Twitter-Based Review
FDA Avandia Panel: A Twitter-Based Review Forbes
View ArticleU.S. FDA panel revisits Avandia, likely too late for diabetes drug
U.S. FDA panel revisits Avandia, likely too late for diabetes drug Reuters
View ArticleFDA Advisory Panel Backs Looser Restrictions On Avandia
FDA Advisory Panel Backs Looser Restrictions On Avandia Forbes
View ArticleIs GlaxoSmithKline A Buy After Avandia Win? Yes
Is GlaxoSmithKline A Buy After Avandia Win? Yes Seeking Alpha
View ArticleGlaxo to pay $229 million to settle Avandia suits with eight states
Glaxo to pay $229 million to settle Avandia suits with eight states Yahoo/Reuters
View ArticleFDA overturns safety restrictions on diabetes pill Avandia based on new heart...
FDA overturns safety restrictions on diabetes pill Avandia based on new heart safety data Yahoo/AP
View ArticleThe FDA, The Avandia Diabetes Pill And Meta-Analyses
The FDA, The Avandia Diabetes Pill And Meta-Analyses Pharmalot
View ArticleOdd HDL Finding Seen in Diabetes Trial
Odd HDL Finding Seen in Diabetes Trial MedPage Today
View Article
